Adhesion GPCRs in immunology

Biochemical Pharmacology

Volumn 114, Issue , 2016, Pages 88-102

  Nijmeijer, Saskia ^a   Vischer, Henry F ^a   Leurs, Rob ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Adhesion; aGPCR; GPCR; Immunology; Leucocytes; Signalling

Indexed keywords

G PROTEIN COUPLED RECEPTOR; PROTEIN ADGRE2; PROTEIN ADGRE3; PROTEIN ADGRE5; UNCLASSIFIED DRUG; ANGIOGENIC PROTEIN; BAI1 PROTEIN, HUMAN; CELL ADHESION MOLECULE;

CELL ADHESION; CELL COMMUNICATION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INTRACELLULAR SIGNALING; LEUKOCYTE ACTIVATION; LEUKOCYTE FUNCTION; LEUKOCYTE MIGRATION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; ANIMAL; CYTOLOGY; GRAM NEGATIVE BACTERIUM; LEUKOCYTE; METABOLISM;

ANGIOGENIC PROTEINS; ANIMALS; CELL ADHESION; CELL ADHESION MOLECULES; GRAM-NEGATIVE BACTERIA; HUMANS; LEUKOCYTES; PHAGOCYTOSIS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84964940259     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2016.04.013     Document Type: Review

References (138)

1. [1] Hamann, J., Aust, G., Araç, D., Engel, F.B., Formstone, C., Fredriksson, R., et al. International union of basic and clinical pharmacology. XCIV. Adhesion G protein-coupled receptors. Pharmacol. Rev. 67 (2015), 338–367, 10.1124/pr.114.009647.
2. [2] Langenhan, T., Aust, G., Hamann, J., Sticky signaling–adhesion class G protein-coupled receptors take the stage. Sci. Signal., 6, 2013, re3.
3. [3] Schiöth, H.B., Nordström, K.J.V., Fredriksson, R., The adhesion GPCRs; gene repertoire, phylogeny and evolution. Yona, S., Stacey, M., (eds.) Adhesion-GPCRs, 2010, Springer US, Boston, MA, 1–13, 10.1007/978-1-4419-7913-1_1.
4. [4] Nordström, K.J.V., Lagerström, M.C., Waller, L.M.J., Fredriksson, R., Schiöth, H.B., The secretin GPCRs descended from the family of adhesion GPCRs. Mol. Biol. Evol. 26 (2009), 71–84, 10.1093/molbev/msn228.
5. [5] Abbott, R.J.M., Spendlove, I., Roversi, P., Fitzgibbon, H., Knott, V., Teriete, P., et al. Structural and functional characterization of a novel T cell receptor co-regulatory protein complex, CD97-CD55. J. Biol. Chem. 282 (2007), 22023–22032, 10.1074/jbc.M702588200.
6. [6] Lin, H.-H., Stacey, M., Yona, S., Chang, G.-W., GPS proteolytic cleavage of adhesion-GPCRs. Yona, S., Stacey, M., (eds.) Adhesion-GPCRs, 2010, Springer, US, Boston, MA, 49–58, 10.1007/978-1-4419-7913-1_4.
7. [7] Krasnoperov, V., Lu, Y., Buryanovsky, L., Neubert, T.A., Ichtchenko, K., Petrenko, A.G., Post-translational proteolytic processing of the calcium-independent receptor of alpha-latrotoxin (CIRL), a natural chimera of the cell adhesion protein and the G protein-coupled receptor. Role of the G protein-coupled receptor proteolysis site (GPS) motif. J. Biol. Chem. 277 (2002), 46518–46526, 10.1074/jbc.M206415200.
8. [8] Araç, D., Boucard, A.A., Bolliger, M.F., Nguyen, J., Soltis, S.M., Südhof, T.C., et al. A novel evolutionarily conserved domain of cell-adhesion GPCRs mediates autoproteolysis. EMBO J. 31 (2012), 1364–1378, 10.1038/emboj.2012.26.
9. [9] Prömel, S., Langenhan, T., Araç, D., Matching structure with function: the GAIN domain of Adhesion-GPCR and PKD1-like proteins. Trends Pharmacol. Sci. 34 (2013), 470–478, 10.1016/j.tips.2013.06.002.
10. [10] Paavola, K.J., Stephenson, J.R., Ritter, S.L., Alter, S.P., Hall, R.A., The N terminus of the adhesion G protein-coupled receptor GPR56 controls receptor signaling activity. J. Biol. Chem. 286 (2011), 28914–28921, 10.1074/jbc.M111.247973.
11. [11] Smit, M.J., Vischer, H.F., Bakker, R.A., Jongejan, A., Timmerman, H., Pardo, L., et al. Pharmacogenomic and structural analysis of constitutive G protein-coupled receptor activity. Annu. Rev. Pharmacol. Toxicol. 47 (2007), 53–87, 10.1146/annurev.pharmtox.47.120505.105126.
12. [12] Liebscher, I., Schön, J., Petersen, S.C., Fischer, L., Auerbach, N., Demberg, L.M., et al. A Tethered agonist within the ectodomain activates the adhesion G protein-coupled receptors GPR126 and GPR133. Cell Rep. 9 (2014), 2018–2026, 10.1016/j.celrep.2014.11.036.
13. [13] Stoveken, H.M., Hajduczok, A.G., Xu, L., Tall, G.G., Adhesion G protein-coupled receptors are activated by exposure of a cryptic tethered agonist. Proc. Natl. Acad. Sci., 2015, 201421785, 10.1073/pnas.1421785112.
14. [14] Demberg, L.M., Rothemund, S., Schöneberg, T., Liebscher, I., Identification of the tethered peptide agonist of the adhesion G protein-coupled receptor GPR64/ADGRG2. Biochem. Biophys. Res. Commun. 464 (2015), 743–747, 10.1016/j.bbrc.2015.07.020.
15. [15] Wilde, C., Fischer, L., Lede, V., Kirchberger, J., Rothemund, S., Schöneberg, T., et al. The constitutive activity of the adhesion GPCR GPR114/ADGRG5 is mediated by its tethered agonist. FASEB J., 2015, 10.1096/fj.15-276220.
16. [16] Kishore, A., Purcell, R.H., Nassiri-Toosi, Z., Hall, R.A., Stalk-dependent and stalk-independent signaling by the adhesion G protein-coupled receptors GPR56 (ADGRG1) and BAI1 (ADGRB1). J. Biol. Chem., 2015 jbc.M115.689349.
17. [17] Peeters, M.C., Fokkelman, M., Boogaard, B., Egerod, K.L., van de Water, B., Ijzerman, A.P., et al. The adhesion G protein-coupled receptor G2 (ADGRG2/GPR64) constitutively activates SRE and NFκB and is involved in cell adhesion and migration. Cell. Signal. 27 (2015), 2579–2588, 10.1016/j.cellsig.2015.08.015.
18. [18] Overington, J.P., Al-Lazikani, B., Hopkins, A.L., How many drug targets are there?. Nat. Rev. Drug Discov. 5 (2006), 993–996, 10.1038/nrd2199.
19. [19] Piao, X., Chang, B.S., Bodell, A., Woods, K., BenZeev, B., Guerrini, R., et al. Genotype–phenotype analysis of human frontoparietal polymicrogyria syndromes. Ann. Neurol. 58 (2005), 680–687.
20. [20] Luo, R., Jin, Z., Deng, Y., Strokes, N., Piao, X., Disease-associated mutations prevent GPR56-collagen III interaction. PLoS One, 7, 2012, e29818, 10.1371/journal.pone.0029818.
21. [21] Weston, M.D., Luijendijk, M., Humphrey, K.D., Moller, C., Kimberling, W.J., Mutations in the VLGR1 gene implicate G-protein signaling in the pathogenesis of Usher syndrome type II. Am. J. Hum. Genet. 74 (2004), 357–366, 10.1086/381685.
22. [22] Bjarnadóttir, T.K., Fredriksson, R., Schiöth, H.B., The adhesion GPCRs: a unique family of G protein-coupled receptors with important roles in both central and peripheral tissues. Cell. Mol. Life Sci. 64 (2007), 2104–2119, 10.1007/s00018-007-7067-1.
23. [23] Fredriksson, R., Lagerström, M.C., Höglund, P.J., Schiöth, H.B., Novel human G protein-coupled receptors with long N-terminals containing GPS domains and Ser/Thr-rich regions. FEBS Lett. 531 (2002), 407–414.
24. [24] Vallon, M., Essler, M., Proteolytically processed soluble tumor endothelial marker (TEM) 5 mediates endothelial cell survival during angiogenesis by linking integrin alpha(v)beta3 to glycosaminoglycans. J. Biol. Chem. 281 (2006), 34179–34188, 10.1074/jbc.M605291200.
25. [25] Wang, X.-J., Zhang, D.-L., Xu, Z.-G., Ma, M.-L., Wang, W.-B., Li, L.-L., et al. Understanding cadherin EGF LAG seven-pass G-type receptors. J. Neurochem. 131 (2014), 699–711, 10.1111/jnc.12955.
26. [26] Bjarnadóttir, T.K., Fredriksson, R., Höglund, P.J., Gloriam, D.E., Lagerstrom, M.C., Schiöth, H.B., The human and mouse repertoire of the adhesion family of G protein-coupled receptors. Genomics 84 (2004), 23–33.
27. [27] Lum, A.M., Wang, B.B., Beck-Engeser, G.B., Li, L., Channa, N., Wabl, M., Orphan receptor GPR110, an oncogene overexpressed in lung and prostate cancer. BMC Cancer, 10, 2010, 1, 10.1186/1471-2407-10-40.
28. [28] Abe, J., Fukuzawa, T., Hirose, S., Cleavage of Ig-Hepta at a “SEA” module and at a conserved G protein-coupled receptor proteolytic site. J. Biol. Chem. 277 (2002), 23391–23398, 10.1074/jbc.M110877200.
29. [29] Abe, J., Suzuki, H., Notoya, M., Yamamoto, T., Hirose, S., Ig-hepta, a novel member of the G protein-coupled hepta-helical receptor (GPCR) family that has immunoglobulin-like repeats in a long N-terminal extracellular domain and defines a new subfamily of GPCRs. J. Biol. Chem. 274 (1999), 19957–19964, 10.1074/jbc.274.28.19957.
30. [30] LopezJimenez, N.D., Sainz, E., Cavenagh, M.M., Cruz-Ithier, M.A., Blackwood, C.A., Battey, J.F., et al. Two novel genes, Gpr113, which encodes a family 2 G-protein-coupled receptor, and Trcg1, are selectively expressed in taste receptor cells. Genomics 85 (2005), 472–482, 10.1016/j.ygeno.2004.12.005.
31. [31] Fredriksson, R., Gloriam, D.E.I., Höglund, P.J., Lagerström, M.C., Schiöth, H.B., There exist at least 30 human G-protein-coupled receptors with long Ser/Thr-rich N-termini. Biochem. Biophys. Res. Commun. 301 (2003), 725–734.
32. [32] Moriguchi, T., Haraguchi, K., Ueda, N., Okada, M., Furuya, T., Akiyama, T., DREG, a developmentally regulated G protein-coupled receptor containing two conserved proteolytic cleavage sites. Genes Cells 9 (2004), 549–560, 10.1111/j.1356-9597.2004.00743.x.
33. [33] Xu, L., Begum, S., Hearn, J.D., Hynes, R.O., GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis. Proc. Natl. Acad. Sci. U.S.A. 103 (2006), 9023–9028, 10.1073/pnas.0602681103.
34. [34] Luo, R., Jeong, S.-J., Jin, Z., Strokes, N., Li, S., Piao, X., G protein-coupled receptor 56 and collagen III, a receptor-ligand pair, regulates cortical development and lamination. Proc. Natl. Acad. Sci. 108 (2011), 12925–12930, 10.1073/pnas.1104821108.
35. [35] Gupte, J., Swaminath, G., Danao, J., Tian, H., Li, Y., Wu, X., Signaling property study of adhesion G-protein-coupled receptors. FEBS Lett. 586 (2012), 1214–1219, 10.1016/j.febslet.2012.03.014.
36. [36] Paavola, K.J., Sidik, H., Zuchero, J.B., Eckart, M., Talbot, W.S., Type IV collagen is an activating ligand for the adhesion G protein-coupled receptor GPR126. Sci. Signal., 7, 2014, ra76, 10.1126/scisignal.2005347.
37. [37] Petersen, S.C., Luo, R., Liebscher, I., Giera, S., Jeong, S.-J., Mogha, A., et al. The adhesion GPCR GPR126 has distinct, domain-dependent functions in schwann cell Development mediated by interaction with laminin-211. Neuron 85 (2015), 755–769, 10.1016/j.neuron.2014.12.057.
38. [38] McMillan, D.R., White, P.C., Studies on the very large g protein-coupled receptor: from initial discovery to determining its role in sensorineural deafness in higher animals. Yona, S., Stacey, M., (eds.) Adhesion-GPCRs, 2010, Springer, US, Boston, MA, 76–86, 10.1007/978-1-4419-7913-1_6.
39. [39] Krasnoperov, V.G., Bittner, M.A., Beavis, R., Kuang, Y., Salnikow, K.V., Chepurny, O.G., et al. Alpha-Latrotoxin stimulates exocytosis by the interaction with a neuronal G-protein-coupled receptor. Neuron 18 (1997), 925–937.
40. [40] Lelianova, V.G., Davletov, B.A., Sterling, A., Rahman, M.A., Grishin, E.V., Totty, N.F., et al. Alpha-latrotoxin receptor, latrophilin, is a novel member of the secretin family of G protein-coupled receptors. J. Biol. Chem. 272 (1997), 21504–21508.
41. [41] Krasnoperov, V., Bittner, M.A., Holz, R.W., Chepurny, O., Petrenko, A.G., Structural requirements for alpha-latrotoxin binding and alpha-latrotoxin-stimulated secretion. A study with calcium-independent receptor of alpha-latrotoxin (CIRL) deletion mutants. J. Biol. Chem. 274 (1999), 3590–3596.
42. [42] Silva, J.P., Lelianova, V.G., Ermolyuk, Y.S., Vysokov, N., Hitchen, P.G., Berninghausen, O., et al. Latrophilin 1 and its endogenous ligand Lasso/teneurin-2 form a high-affinity transsynaptic receptor pair with signaling capabilities. Proc. Natl. Acad. Sci. 108 (2011), 12113–12118, 10.1073/pnas.1019434108.
43. [43] Boucard, A.A., Maxeiner, S., Südhof, T.C., Latrophilins function as heterophilic cell-adhesion molecules by binding to teneurins: regulation by alternative splicing. J. Biol. Chem. 289 (2014), 387–402, 10.1074/jbc.M113.504779.
44. [44] Koh, J.T., Kook, H., Kee, H.J., Seo, Y.-W., Jeong, B.C., Lee, J.H., et al. Extracellular fragment of brain-specific angiogenesis inhibitor 1 suppresses endothelial cell proliferation by blocking αvβ5 integrin. Exp. Cell Res. 294 (2004), 172–184, 10.1016/j.yexcr.2003.11.008.
45. [45] Duman, J.G., Tu, Y.K., Tolias, K.F., Emerging roles of BAI adhesion-GPCRs in synapse development and plasticity. Neural Plast., 2015.
46. [46] Kaur, B., Brat, D.J., Devi, N.S., Van Meir, E.G., Vasculostatin, a proteolytic fragment of brain angiogenesis inhibitor 1, is an antiangiogenic and antitumorigenic factor. Oncogene 24 (2005), 3632–3642, 10.1038/sj.onc.1208317.
47. [47] Cork, S.M., Kaur, B., Devi, N.S., Cooper, L., Saltz, J.H., Sandberg, E.M., et al. A proprotein convertase/MMP-14 proteolytic cascade releases a novel 40 kDa vasculostatin from tumor suppressor BAI1. Oncogene 31 (2012), 5144–5152, 10.1038/onc.2012.1.
48. [48] Park, D., Tosello-Trampont, A.-C., Elliott, M.R., Lu, M., Haney, L.B., Ma, Z., et al. BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature 450 (2007), 430–434, 10.1038/nature06329.
49. [49] Mazaheri, F., Breus, O., Durdu, S., Haas, P., Wittbrodt, J., Gilmour, D., et al. Distinct roles for BAI1 and TIM-4 in the engulfment of dying neurons by microglia. Nat. Commun., 5, 2014, 10.1038/ncomms5046.
50. [50] Das, S., Owen, K.A., Ly, K.T., Park, D., Black, S.G., Wilson, J.M., et al. Brain angiogenesis inhibitor 1 (BAI1) is a pattern recognition receptor that mediates macrophage binding and engulfment of Gram-negative bacteria. Proc. Natl. Acad. Sci. 108 (2011), 2136–2141, 10.1073/pnas.1014775108.
51. [51] D'Souza, S.E., Ginsberg, M.H., Plow, E.F., Arginyl-glycyl-aspartic acid (RGD): a cell adhesion motif. Trends Biochem. Sci. 16 (1991), 246–250, 10.1016/0968-0004(91)90096-E.
52. [52] Baud, V., Chissoe, S.L., Viegas-Péquignot, E., Diriong, S., N'Guyen, V.C., Roe, B.A., et al. EMR1, an unusual member in the family of hormone receptors with seven transmembrane segments. Genomics 26 (1995), 334–344.
53. [53] McKnight, A.J., Macfarlane, A.J., Dri, P., Turley, L., Willis, A.C., Gordon, S., Molecular cloning of F4/80, a murine macrophage-restricted cell surface glycoprotein with homology to the G-protein-linked transmembrane 7 hormone receptor family. J. Biol. Chem. 271 (1996), 486–489.
54. [54] Lin, H.H., Stubbs, L.J., Mucenski, M.L., Identification and characterization of a seven transmembrane hormone receptor using differential display. Genomics 41 (1997), 301–308, 10.1006/geno.1997.4674.
55. [55] Lin, H.H., Stacey, M., Hamann, J., Gordon, S., McKnight, A.J., Human EMR2, a novel EGF-TM7 molecule on chromosome 19p13.1, is closely related to CD97. Genomics 67 (2000), 188–200, 10.1006/geno.2000.6238.
56. [56] Stacey, M., Lin, H.H., Hilyard, K.L., Gordon, S., McKnight, A.J., Human epidermal growth factor (EGF) module-containing mucin-like hormone receptor 3 is a new member of the EGF-TM7 family that recognizes a ligand on human macrophages and activated neutrophils. J. Biol. Chem. 276 (2001), 18863–18870, 10.1074/jbc.M101147200.
57. [57] Stacey, M., Chang, G.-W., Sanos, S.L., Chittenden, L.R., Stubbs, L., Gordon, S., et al. EMR4, a novel epidermal growth factor (EGF)-TM7 molecule up-regulated in activated mouse macrophages, binds to a putative cellular ligand on B lymphoma cell line A20. J. Biol. Chem. 277 (2002), 29283–29293, 10.1074/jbc.M204306200.
58. [58] Hamann, J., Kwakkenbos, M.J., de Jong, E.C., Heus, H., Olsen, A.S., van Lier, R.A.W., Inactivation of the EGF-TM7 receptor EMR4 after the Pan-Homo divergence. Eur. J. Immunol. 33 (2003), 1365–1371, 10.1002/eji.200323881.
59. [59] Caminschi, I., Lucas, K.M., O'Keeffe, M.A., Hochrein, H., Laâbi, Y., Köntgen, F., et al. Molecular cloning of F4/80-like-receptor, a seven-span membrane protein expressed differentially by dendritic cell and monocyte-macrophage subpopulations. J. Immunol. 167 (2001), 3570–3576.
60. [60] Hamann, J., Hartmann, E., van Lier, R.A.W., Structure of the human CD97 gene: exon shuffling has generated a new type of seven-span transmembrane molecule related to the secretin receptor superfamily. Genomics 32 (1996), 144–147, 10.1006/geno.1996.0092.
61. [61] Eichler, W., Aust, G., Hamann, D., Characterization of an early activation-dependent antigen on lymphocytes defined by the monoclonal antibody BL-Ac(F2). Scand. J. Immunol. 39 (1994), 111–115.
62. [62] Hamann, J., Eichler, W., Hamann, D., Kerstens, H.M., Poddighe, P.J., Hoovers, J.M., et al. Expression cloning and chromosomal mapping of the leukocyte activation antigen CD97, a new seven-span transmembrane molecule of the secretion receptor superfamily with an unusual extracellular domain. J. Immunol. 155 (1995), 1942–1950.
63. [63] Gray, J.X., Haino, M., Roth, M.J., Maguire, J.E., Jensen, P.N., Yarme, A., et al. CD97 is a processed, seven-transmembrane, heterodimeric receptor associated with inflammation. J. Immunol. 157 (1996), 5438–5447.
64. [64] Kwakkenbos, M.J., Kop, E.N., Stacey, M., Matmati, M., Gordon, S., Lin, H.-H., et al. The EGF-TM7 family: a postgenomic view. Immunogenetics 55 (2004), 655–666, 10.1007/s00251-003-0625-2.
65. [65] Nishimori, H., Shiratsuchi, T., Urano, T., Kimura, Y., Kiyono, K., Tatsumi, K., et al. A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis. Oncogene 15 (1997), 2145–2150.
66. [66] Sokolowski, J.D., Nobles, S.L., Heffron, D.S., Park, D., Ravichandran, K.S., Mandell, J.W., Brain-specific angiogenesis inhibitor-1 expression in astrocytes and neurons: implications for its dual function as an apoptotic engulfment receptor. Brain Behav. Immun. 25 (2011), 915–921, 10.1016/j.bbi.2010.09.021.
67. [67] Mori, K., Kanemura, Y., Fujikawa, H., Nakano, A., Ikemoto, H., Ozaki, I., et al. Brain-specific angiogenesis inhibitor 1 (BAI1) is expressed in human cerebral neuronal cells. Neurosci. Res. 43 (2002), 69–74.
68. [68] Duman, J.G., Tzeng, C.P., Tu, Y.-K., Munjal, T., Schwechter, B., Ho, T.S.-Y., et al. The adhesion-GPCR BAI1 regulates synaptogenesis by controlling the recruitment of the Par3/Tiam1 polarity complex to synaptic sites. J. Neurosci. 33 (2013), 6964–6978, 10.1523/JNEUROSCI.3978-12.2013.
69. [69] Stephenson, J.R., Purcell, R.H., Hall, R.A., The BAI subfamily of adhesion GPCRs: synaptic regulation and beyond. Trends Pharmacol. Sci. 35 (2014), 208–215, 10.1016/j.tips.2014.02.002.
70. [70] Fadok, V.A., Xue, D., Henson, P., If phosphatidylserine is the death knell, a new phosphatidylserine-specific receptor is the bellringer. Cell Death Differ., 2001.
71. [71] Das, S., Sarkar, A., Ryan, K.A., Fox, S., Berger, A.H., Juncadella, I.J., et al. Brain angiogenesis inhibitor 1 is expressed by gastric phagocytes during infection with Helicobacter pylori and mediates the recognition and engulfment of human apoptotic gastric epithelial cells. FASEB J. 28 (2014), 2214–2224, 10.1096/fj.13-243238.
72. [72] Billings, E.A., Lee, C.S., Owen, K.A., D'Souza, R.S., Ravichandran, K.S., Casanova, J.E., The adhesion GPCR BAI1 mediates macrophage ROS production and microbicidal activity against Gram-negative bacteria. Sci. Signal., 9, 2016, ra14, 10.1126/scisignal.aac6250.
73. [73] Gumienny, T.L., Brugnera, E., Tosello-Trampont, A.C., Kinchen, J.M., Haney, L.B., Nishiwaki, K., et al. CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration. Cell 107 (2001), 27–41.
74. [74] Vigil, D., Cherfils, J., Rossman, K.L., Der, C.J., Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?. Nat. Rev. Cancer 10 (2010), 842–857, 10.1038/nrc2960.
75. [75] Côté, J.-F., Vuori, K., GEF what? Dock180 and related proteins help Rac to polarize cells in new ways. Trends Cell Biol. 17 (2007), 383–393, 10.1016/j.tcb.2007.05.001.
76. [76] Cherfils, J., Chardin, P., GEFs: structural basis for their activation of small GTP-binding proteins. Trends Biochem. Sci. 24 (1999), 306–311.
77. [77] Noubade, R., Wong, K., Ota, N., Rutz, S., Eidenschenk, C., Valdez, P.A., et al. NRROS negatively regulates reactive oxygen species during host defence and autoimmunity. Nature 509 (2014), 235–239, 10.1038/nature13152.
78. [78] Gorzalczany, Y., Sigal, N., Itan, M., Lotan, O., Pick, E., Targeting of Rac1 to the phagocyte membrane is sufficient for the induction of NADPH oxidase assembly. J. Biol. Chem. 275 (2000), 40073–40081, 10.1074/jbc.M006013200.
79. [79] Groemping, Y., Rittinger, K., Activation and assembly of the NADPH oxidase: a structural perspective. Biochem. J. 386 (2005), 401–416, 10.1042/BJ20041835.
80. [80] Baranova, I.N., Kurlander, R., Bocharov, A.V., Vishnyakova, T.G., Chen, Z., Remaley, A.T., et al. Role of human CD36 in bacterial recognition, phagocytosis, and pathogen-induced JNK-mediated signaling. J. Immunol. 181 (2008), 7147–7156.
81. [81] Silverstein, R.L., Febbraio, M., CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci. Signal., 2, 2009, re3 10.1126/scisignal.272re3.
82. [82] Stephenson, J.R., Paavola, K.J., Schaefer, S.A., Kaur, B., Van Meir, E.G., Hall, R.A., Brain-specific angiogenesis inhibitor-1 signaling, regulation, and enrichment in the postsynaptic density. J. Biol. Chem. 288 (2013), 22248–22256, 10.1074/jbc.M113.489757.
83. [83] Lanoue, V., Usardi, A., Sigoillot, S.M., Talleur, M., Iyer, K., Mariani, J., et al. The adhesion-GPCR BAI3, a gene linked to psychiatric disorders, regulates dendrite morphogenesis in neurons. Mol. Psychiatry 18 (2013), 943–950, 10.1038/mp.2013.46.
84. [84] Gordon, S., Hamann, J., Lin, H.H., F4/80 and the related adhesion-GPCRs. Eur. J. Immunol., 2011 Wiley Online Library.
85. 111In-anti-F4/80-A3-1 antibody: a novel tracer to image macrophages. Eur. J. Nucl. Med. Mol. Imaging 42 (2015), 1430–1438, 10.1007/s00259-015-3084-8.
86. [86] Ezekowitz, R.A., Austyn, J., Stahl, P.D., Gordon, S., Surface properties of bacillus Calmette-Guérin-activated mouse macrophages. Reduced expression of mannose-specific endocytosis, Fc receptors, and antigen F4/80 accompanies induction of Ia. J. Exp. Med. 154 (1981), 60–76.
87. [87] Ezekowitz, R.A., Gordon, S., Down-regulation of mannosyl receptor-mediated endocytosis and antigen F4/80 in bacillus Calmette-Guérin-activated mouse macrophages. Role of T lymphocytes and lymphokines. J. Exp. Med. 155 (1982), 1623–1637.
88. [88] Hamann, J., Koning, N., Pouwels, W., Ulfman, L.H., van Eijk, M., Stacey, M., et al. EMR1, the human homolog of F4/80, is an eosinophil-specific receptor. Eur. J. Immunol. 37 (2007), 2797–2802, 10.1002/eji.200737553.
89. [89] Warschkau, H., Kiderlen, A.F., A monoclonal antibody directed against the murine macrophage surface molecule F4/80 modulates natural immune response to Listeria monocytogenes. J. Immunol. 163 (1999), 3409–3416.
90. [90] Wilbanks, G.A., Mammolenti, M., Streilein, J.W., Studies on the induction of anterior chamber-associated immune deviation (ACAID). II. Eye-derived cells participate in generating blood-borne signals that induce ACAID. J. Immunol. 146 (1991), 3018–3024.
91. [91] Lin, H.-H., Faunce, D.E., Stacey, M., Terajewicz, A., Nakamura, T., Zhang-Hoover, J., et al. The macrophage F4/80 receptor is required for the induction of antigen-specific efferent regulatory T cells in peripheral tolerance. J. Exp. Med. 201 (2005), 1615–1625, 10.1084/jem.20042307.
92. [92] Schaller, E., Macfarlane, A.J., Rupec, R.A., Gordon, S., McKnight, A.J., Pfeffer, K., Inactivation of the F4/80 glycoprotein in the mouse germ line. Mol. Cell. Biol. 22 (2002), 8035–8043, 10.1128/MCB.22.22.8035-8043.2002.
93. [93] Sonoda, K.H., Exley, M., Snapper, S., Balk, S.P., Stein-Streilein, J., CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J. Exp. Med. 190 (1999), 1215–1226.
94. [94] Legrand, F., Tomasevic, N., Simakova, O., Lee, C.-C.R., Wang, Z., Raffeld, M., The eosinophil surface receptor epidermal growth factor-like module containing mucin-like hormone receptor 1 (EMR1): a novel therapeutic target for eosinophilic disorders. J. Allergy Clin. Immunol. 133 (2014), 1439–1447, 10.1016/j.jaci.2013.11.041 e1–8.
95. [95] Kwakkenbos, M.J., Chang, G.-W., Lin, H.-H., Pouwels, W., de Jong, E.C., van Lier, R.A.W., et al. The human EGF-TM7 family member EMR2 is a heterodimeric receptor expressed on myeloid cells. J. Leukoc. Biol. 71 (2002), 854–862.
96. [96] Kop, E.N., Kwakkenbos, M.J., Teske, G.J.D., Kraan, M.C., Smeets, T.J., Stacey, M., et al. Identification of the epidermal growth factor-TM7 receptor EMR2 and its ligand dermatan sulfate in rheumatoid synovial tissue. Arthritis Rheumatol. 52 (2005), 442–450, 10.1002/art.20788.
97. [97] Chang, G.-W., Davies, J.Q., Stacey, M., Yona, S., Bowdish, D.M.E., Hamann, J., et al. CD312, the human adhesion-GPCR EMR2, is differentially expressed during differentiation, maturation, and activation of myeloid cells. Biochem. Biophys. Res. Commun. 353 (2007), 133–138, 10.1016/j.bbrc.2006.11.148.
98. [98] Chen, T.-Y., Hwang, T.-L., Lin, C.-Y., Lin, T.-N., Lai, H.-Y., Tsai, W.-P., et al. EMR2 receptor ligation modulates cytokine secretion profiles and cell survival of lipopolysaccharide-treated neutrophils. Chang Gung Med. J. 34 (2011), 468–477.
99. [99] Yona, S., Lin, H.-H., Dri, P., Davies, J.Q., Hayhoe, R.P.G., Lewis, S.M., et al. Ligation of the adhesion-GPCR EMR2 regulates human neutrophil function. FASEB J. 22 (2008), 741–751, 10.1096/fj.07-9435com.
100. [100] Lewis, S.M., Treacher, D.F., Edgeworth, J., Mahalingam, G., Brown, C.S., Mare, T.A., et al. Expression of CD11c and EMR2 on neutrophils: potential diagnostic biomarkers for sepsis and systemic inflammation. Clin. Exp. Immunol. 182 (2015), 184–194, 10.1111/cei.12679.
101. [101] Huang, Y.-S., Chiang, N.-Y., Hu, C.-H., Hsiao, C.-C., Cheng, K.-F., Tsai, W.-P., et al. Activation of myeloid cell-specific adhesion class G protein-coupled receptor EMR2 via ligation-induced translocation and interaction of receptor subunits in lipid raft microdomains. Mol. Cell. Biol. 32 (2012), 1408–1420, 10.1128/MCB.06557-11.
102. [102] Matmati, M., Pouwels, W., van Bruggen, R., Jansen, M., Hoek, R.M., Verhoeven, A.J., et al. The human EGF-TM7 receptor EMR3 is a marker for mature granulocytes. J. Leukoc. Biol. 81 (2007), 440–448, 10.1189/jlb.0406276.
103. [103] Kop, E.N., EGF-TM7 receptors in rheumatoid arthritis. (PhD thesis), 2011 http://hdl.handle.net/11245/1.366181.
104. [104] Jaspars, L.H., Vos, W., Aust, G., van Lier, R.A., Hamann, J., Tissue distribution of the human CD97 EGF-TM7 receptor. Tissue Antigens 57 (2001), 325–331.
105. [105] Eichler, W., Hamann, J., Aust, G., Expression characteristics of the human CD97 antigen. Tissue Antigens 50 (1997), 429–438.
106. [106] van Eijk, M., Aust, G., Brouwer, M.S.M., van Meurs, M., Voerman, J.S.A., Dijke, I.E., et al. Differential expression of the EGF-TM7 family members CD97 and EMR2 in lipid-laden macrophages in atherosclerosis, multiple sclerosis and Gaucher disease. Immunol. Lett. 129 (2010), 64–71, 10.1016/j.imlet.2010.02.004.
107. [107] Kop, E.N., Matmati, M., Pouwels, W., Leclercq, G., Tak, P.P., Hamann, J., Differential expression of CD97 on human lymphocyte subsets and limited effect of CD97 antibodies on allogeneic T-cell stimulation. Immunol. Lett. 123 (2009), 160–168, 10.1016/j.imlet.2009.03.009.
108. [108] Wandel, E., Saalbach, A., Sittig, D., Gebhardt, C., Aust, G., Thy-1 (CD90) is an interacting partner for CD97 on activated endothelial cells. J. Immunol. 188 (2012), 1442–1450, 10.4049/jimmunol.1003944.
109. [109] Visser, L., de Vos, A.F., Hamann, J., Melief, M.-J., van Meurs, M., van Lier, R.A.W., et al. Expression of the EGF-TM7 receptor CD97 and its ligand CD55 (DAF) in multiple sclerosis. J. Neuroimmunol. 132 (2002), 156–163.
110. [110] Qian, Y.M., Haino, M., Kelly, K., Song, W.C., Structural characterization of mouse CD97 and study of its specific interaction with the murine decay-accelerating factor (DAF, CD55). Immunology 98 (1999), 303–311, 10.1046/j.1365-2567.1999.00859.x.
111. [111] Hamann, J., van Zeventer, C., Bijl, A., Molenaar, C., Tesselaar, K., van Lier, R.A., Molecular cloning and characterization of mouse CD97. Int. Immunol. 12 (2000), 439–448.
112. [112] Hamann, J., Vogel, B., van Schijndel, G.M., van Lier, R.A., The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF). J. Exp Med. 184 (1996), 1185–1189.
113. [113] Stacey, M., Chang, G.-W., Davies, J.Q., Kwakkenbos, M.J., Sanderson, R.D., Hamann, J., et al. The epidermal growth factor-like domains of the human EMR2 receptor mediate cell attachment through chondroitin sulfate glycosaminoglycans. Blood 102 (2003), 2916–2924, 10.1182/blood-2002-11-3540.
114. [114] Wang, T., Ward, Y., Tian, L., Lake, R., Guedez, L., Stetler-Stevenson, W.G., et al. CD97, an adhesion receptor on inflammatory cells, stimulates angiogenesis through binding integrin counter receptors on endothelial cells. Blood 105 (2005), 2836–2844, 10.1182/blood-2004-07-2878.
115. [115] Lin, H.H., Stacey, M., Saxby, C., Knott, V., Chaudhry, Y., Evans, D., et al. Molecular analysis of the epidermal growth factor-like short consensus repeat domain-mediated protein-protein interactions: dissection of the CD97-CD55 complex. J. Biol. Chem. 276 (2001), 24160–24169, 10.1074/jbc.M101770200.
116. [116] Hamann, J., Stortelers, C., Kiss-Toth, E., Characterization of the CD55 (DAF)-binding site on the seven-span transmembrane receptor CD97. Eur. J. Immunol., 1998.
117. [117] Leemans, J.C., te Velde, A.A., Florquin, S., Bennink, R.J., de Bruin, K., van Lier, R.A.W., et al. The epidermal growth factor-seven transmembrane (EGF-TM7) receptor CD97 is required for neutrophil migration and host defense. J. Immunol. 172 (2004), 1125–1131.
118. [118] Kwakkenbos, M.J., Pouwels, W., Matmati, M., Stacey, M., Lin, H.-H., Gordon, S., et al. Expression of the largest CD97 and EMR2 isoforms on leukocytes facilitates a specific interaction with chondroitin sulfate on B cells. J. Leukoc. Biol. 77 (2005), 112–119, 10.1189/jlb.0704402.
119. [119] Hamann, J., Wishaupt, J.O., Van-Lier, R., Smeets, T., Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue. Arthritis Rheumatol., 2001.
120. [120] van Lier, R.A., Eichler, W., Hamann, J., Sevenspan transmembrane molecules: novel receptors involved in leukocyte adhesion. Immunol. Lett. 54 (1996), 185–187.
121. [121] Wang, T., Tian, L., Haino, M., Gao, J.-L., Lake, R., Ward, Y., et al. Improved antibacterial host defense and altered peripheral granulocyte homeostasis in mice lacking the adhesion class G protein receptor CD97. Infect. Immun. 75 (2007), 1144–1153, 10.1128/IAI.00869-06.
122. [122] Hamann, J., Wishaupt, J.O., van Lier, R.A., Smeets, T.J., Breedveld, F.C., Tak, P.P., Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue. Arthritis Rheumatol. 42 (1999), 650–658, 10.1002/1529-0131(199904)42:4<650::AID-ANR7>3.0.CO;2-S.
123. [123] Kop, E.N., Adriaansen, J., Smeets, T., CD97 neutralization increases resistance to collagen-induced arthritis in mice. Arthritis Res. Ther., 2006.
124. [124] Hoek, R.M., de Launay, D., Kop, E.N., Yilmaz-Elis, A.S., Lin, F., Reedquist, K.A., et al. Deletion of either CD55 or CD97 ameliorates arthritis in mouse models. Arthritis Rheumatol. 62 (2010), 1036–1042, 10.1002/art.27347.
125. [125] Galle, J., Sittig, D., Hanisch, I., Wobus, M., Wandel, E., Loeffler, M., et al. Individual cell-based models of tumor-environment interactions: Multiple effects of CD97 on tumor invasion. Am. J. Pathol. 169 (2006), 1802–1811, 10.2353/ajpath.2006.060006.
126. [126] Karpus, O.N., Veninga, H., Hoek, R.M., Flierman, D., van Buul, J.D., vandenAkker, C.C., et al. Shear stress-dependent downregulation of the adhesion-G protein-coupled receptor CD97 on circulating leukocytes upon contact with its ligand CD55. J. Immunol. 190 (2013), 3740–3748, 10.4049/jimmunol.1202192.
127. [127] Wobus, M., Vogel, B., Schmücking, E., Hamann, J., Aust, G., N-glycosylation of CD97 within the EGF domains is crucial for epitope accessibility in normal and malignant cells as well as CD55 ligand binding. Int. J. Cancer 112 (2004), 815–822, 10.1002/ijc.20483.
128. [128] Becker, S., Wandel, E., Wobus, M., Schneider, R., Amasheh, S., Sittig, D., et al. Overexpression of CD97 in intestinal epithelial cells of transgenic mice attenuates colitis by strengthening adherens junctions. PLoS One, 5, 2010, e8507, 10.1371/journal.pone.0008507.
129. [129] Ward, Y., Lake, R., Yin, J.J., Heger, C.D., Raffeld, M., Goldsmith, P.K., et al. LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHO-dependent signaling and invasion in prostate cancer cells. Cancer Res. 71 (2011), 7301–7311, 10.1158/0008-5472.CAN-11-2381.
130. [130] Hsiao, C.-C., Chen, H.-Y., Chang, G.-W., Lin, H.-H., GPS autoproteolysis is required for CD97 to up-regulate the expression of N-cadherin that promotes homotypic cell-cell aggregation. FEBS Lett. 585 (2011), 313–318, 10.1016/j.febslet.2010.12.005.
131. [131] Ward, Y., Lake, R., Martin, P.L., Killian, K., Salerno, P., Wang, T., et al. CD97 amplifies LPA receptor signaling and promotes thyroid cancer progression in a mouse model. Oncogene 32 (2012), 2726–2738, 10.1038/onc.2012.301.
132. [132] Harvey, R.C., Mullighan, C.G., Wang, X., Dobbin, K.K., Davidson, G.S., Bedrick, E.J., et al. Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. Blood 116 (2010), 4874–4884, 10.1182/blood-2009-08-239681.
133. [133] Sugimura, R., He, X.C., Venkatraman, A., Arai, F., Box, A., Semerad, C., et al. Noncanonical Wnt signaling maintains hematopoietic stem cells in the niche. Cell 150 (2012), 351–365, 10.1016/j.cell.2012.05.041.
134. [134] Peng, Y.-M., van de Garde, M.D.B., Cheng, K.-F., Baars, P.A., Remmerswaal, E.B.M., van Lier, R.A.W., et al. Specific expression of GPR56 by human cytotoxic lymphocytes. J. Leukoc. Biol. 90 (2011), 735–740, 10.1189/jlb.0211092.
135. [135] Della Chiesa, M., Falco, M., Parolini, S., Bellora, F., Petretto, A., Romeo, E., et al. GPR56 as a novel marker identifying the CD56dull CD16+ NK cell subset both in blood stream and in inflamed peripheral tissues. Int. Immunol. 22 (2010), 91–100, 10.1093/intimm/dxp116.
136. [136] Sleckman, B.P., Khan, W.N., Xu, W., Bassing, C.H., Malynn, B.A., Copeland, N.G., et al. Cloning and functional characterization of the early-lymphocyte-specific Pb99 gene. Mol. Cell. Biol. 20 (2000), 4405–4410, 10.1128/MCB.20.12.4405-4410.2000.
137. [137] Wang, J.-J., Zhang, L.-L., Zhang, H.-X., Shen, C.-L., Lu, S.-Y., Kuang, Y., et al. Gpr97 is essential for the follicular versus marginal zone B-lymphocyte fate decision. Cell Death Dis., 4, 2013, e853, 10.1038/cddis.2013.346.
138. [138] Shi, J.-P., Li, X.-N., Zhang, X.-Y., Du, B., Jiang, W.-Z., Liu, M.-Y., et al. Gpr97 Is dispensable for inflammation in OVA-induced asthmatic mice. PLoS One, 10, 2015, e0131461, 10.1371/journal.pone.0131461.